Account
Watchlists
Bookmarks
Pricing
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Fabtech Technologies Limited is a global turnkey engineering solutions provider specializing in the pharmaceutical, biotech, and healthcare sectors. With a presence in over 62 countries, particularly in emerging economies, the company offers comprehensive services from design and engineering to procurement and installation of manufacturing facilities. It operates on an asset-light business model, leveraging an integrated procurement system with related entities and third-party suppliers. Fabtech utilizes its proprietary in-house software, 'FabAssure', for efficient digital project management, and has a strong track record of executing complex projects across diverse dosage forms and challenging geographies.
Sep 29, 2025
Oct 01, 2025
Oct 07, 2025
Mainboard
Closed
—
230.3 Cr
0 Cr
₹181 - ₹191
75
Our Company proposes to utilize the Net Proceeds from the Issue towards funding the following objects:
Funding working capital requirements of the company to support business operations and execute a growing order book, which stands at ₹90,441.87 lakhs as of July 31, 2025. This includes managing advances to suppliers and securing bank guarantees for new projects.
Pursuing inorganic growth initiatives through strategic acquisitions of manufacturers engaged in producing process equipment and other critical components in India, United Arab Emirates, Saudi Arabia, and Egypt to expand execution capabilities and geographic reach.
Funding general corporate purposes, which may include meeting operating expenses, strengthening marketing capabilities, and addressing other business needs not covered by the specific objects of the issue.
—
—
30.46%
24.46%
26.83%
—
13.83%
14.07%
3.57
A leading turnkey engineering solution provider offering comprehensive, integrated services from design to commissioning.
Operates on a scalable, asset-light business model with an established network of related entities for equipment procurement.
Utilizes proprietary in-house software 'FabAssure' for efficient digital project management and real-time monitoring.
Possesses a geographically diversified order book with a strong track record of executing complex projects in over 62 countries.
High dependency on a limited number of large-scale projects, making revenue streams vulnerable to delays or cancellations.
Significant reliance on related party entities for the procurement of key equipment and materials, posing potential conflict-of-interest risks.
Geographic concentration of business in the GCC and MENA regions, which are susceptible to political and economic instability.
Exposure to financial risks from fixed-price contracts, which may lead to reduced profit margins in case of cost overruns.
Leveraging the projected 1.3x increase in global pharmaceutical capex, estimated at $500-550 billion between 2025-2029.
Capitalizing on the growing government focus on localizing pharmaceutical manufacturing in the Middle East and Africa.
Expanding the customer base by securing government-led healthcare infrastructure projects in the under-penetrated African region.
Diversifying revenue streams by targeting non-pharmaceutical sectors such as nutraceuticals and GMP-certified FMCG industries.
Geopolitical instability and regional conflicts in key operational areas could disrupt supply chains and project execution.
Stringent and evolving government regulations, pricing pressures, and compliance requirements in the pharmaceutical industry.
Volatility in foreign exchange rates can adversely impact revenue realization and profitability from international projects.
Intense competition from other turnkey solution providers and challenges in attracting and retaining skilled technical talent.